Agnoli C, Grioni S, Sieri S, Sacerdote C, Vineis P, Tumino R, et al
Link: Key Contributions: This breakthrough announcement detailed the first FDA-approved continuous delivery treatment for diabetic retinopathy
Heart health and weight-related risk Some semaglutide-containing medications are approved to reduce the risk of major heart-related events in certain adults who meet specific criteria
Cryptococcus is ubiquitous and globally distributed, with more than 70 % of children older than 5 demonstrating serum reactivity against cryptococcal proteins [24]
Some participants continued taking it for an additional 52 weeks (for a total of 88 weeks) and had an average weight loss of 26.0% from baseline
When combined with proper nutrition, hydration, and an active lifestyle, they help support a structured wellness journey